🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cisplatin or Carboplatin will be given on day 1 every 21 days for 6 cycles;...
Status
Completed
Location
Princess Margaret Hospital
Start Date
2006-06
Trial ID
NCT00603915
Treatments Being Tested
* The study is evaluating the safety and tolerability of Nivolumab (BMS-936...
Status
Completed
Location
Ucla
Start Date
2011-12-16
Trial ID
NCT01454102
Treatments Being Tested
The purpose of this study is to determine a safe dose of LY573636 (tasisula...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-07
Trial ID
NCT01284335
Treatments Being Tested
Stage IIIA NSCLC represents a relatively heterogeneous group of pts with ip...
Status
Unknown
Location
Guangdong General Hospital
Start Date
2011-12-05
Trial ID
NCT01407822
Treatments Being Tested
The objective of our study is to assess the risk of immune-related adverse ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07-01
Trial ID
NCT04115410
Treatments Being Tested
The current first line treatment of patients with EGFR activating mutation ...
Status
Terminated
Location
CH
Start Date
2014-06
Trial ID
NCT02178397
Treatments Being Tested
This 2 arm study will compare the efficacy and safety of sequential treatme...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00883779
Treatments Being Tested
This 2 arm study will compare the efficacy and safety of treatment with erl...
Status
Unknown
Location
Xinjiang medical university
Start Date
2013-12
Trial ID
NCT02001896
Treatments Being Tested
The objective of this trial is to improve the duration of control disease f...
Status
Completed
Location
Maurice PEROL
Start Date
2006-06
Trial ID
NCT00300586
Treatments Being Tested
This open-label, randomized, parallel arm study assessed the efficacy and s...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01342965
Treatments Being Tested